Related references
Note: Only part of the references are listed.The tetravalent anti-DR5 antibody without cross-linking direct induces apoptosis of cancer cells
Fengtao Liu et al.
BIOMEDICINE & PHARMACOTHERAPY (2015)
Conformation of the Human Immunoglobulin G2 Hinge Imparts Superagonistic Properties to Immunostimulatory Anticancer Antibodies
Ann L. White et al.
CANCER CELL (2015)
Unexpected hepatotoxicity in a phase I study of TAS266, a novel tetravalent agonistic NanobodyA® targeting the DR5 receptor
Kyriakos P. Papadopoulos et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2015)
Structure of FcγRI in complex with Fc reveals the importance of glycan recognition for high-affinity IgG binding
Jinghua Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
TRAIL-R2-specific antibodies and recombinant TRAIL can synergise to kill cancer cells
M. H. Tuthill et al.
ONCOGENE (2015)
Principles and mechanisms of CD95 activation
Harald Wajant
BIOLOGICAL CHEMISTRY (2014)
Apo2L/TRAIL and the Death Receptor 5 Agonist Antibody AMG 655 Cooperate to Promote Receptor Clustering and Antitumor Activity
Jonathan D. Graves et al.
CANCER CELL (2014)
Getting TRAIL back on track for cancer therapy
J. Lemke et al.
CELL DEATH AND DIFFERENTIATION (2014)
OX40 engagement depletes intratumoral Tregs via activating FcγRs, leading to antitumor efficacy
Yannick Bulliard et al.
IMMUNOLOGY AND CELL BIOLOGY (2014)
Safety, pharmacokinetics, and pharmacodynamics of the DR5 antibody LBY135 alone and in combination with capecitabine in patients with advanced solid tumors
Sunil Sharma et al.
INVESTIGATIONAL NEW DRUGS (2014)
Dominant Negative Effects of Tumor Necrosis Factor (TNF)-related Apoptosis-inducing Ligand (TRAIL) Receptor 4 on TRAIL Receptor 1 Signaling by Formation of Heteromeric Complexes
Simon Neumann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies
Shravan Madireddi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Fcγ Receptor Dependency of Agonistic CD40 Antibody in Lymphoma Therapy Can Be Overcome through Antibody Multimerization
Ann L. White et al.
JOURNAL OF IMMUNOLOGY (2014)
Tetravalent Antibody-scTRAIL Fusion Proteins with Improved Properties
Oliver Seifert et al.
MOLECULAR CANCER THERAPEUTICS (2014)
A novel llama antibody targeting Fn14 exhibits anti-metastatic activity in vivo
Johannes Trebing et al.
MABS (2014)
Multivalent nanobodies targeting death receptor 5 elicit superior tumor cell killing through efficient caspase induction
Heather A. Huet et al.
MABS (2014)
Type I and type II Fc receptors regulate innate and adaptive immunity
Andrew Pincetic et al.
NATURE IMMUNOLOGY (2014)
An engineered Fc variant of an IgG eliminates all immune effector functions via structural perturbations
Omid Vafa et al.
METHODS (2014)
HIV-1 Adenoviral Vector Vaccines Expressing Multi-Trimeric BAFF and 4-1BBL Enhance T Cell Mediated Anti-Viral Immunity
Saravana Kanagavelu et al.
PLOS ONE (2014)
Mechanistic Basis for Functional Promiscuity in the TNF and TNF Receptor Superfamilies: Structure of the LIGHT:DcR3 Assembly
Weifeng Liu et al.
STRUCTURE (2014)
Nuclear Factor κB is required for tumor growth inhibition mediated by enavatuzumab (PDL192), a humanized monoclonal antibody to TweakR
James W. Purcell et al.
FRONTIERS IN IMMUNOLOGY (2014)
TNF receptor-associated factor 1 is a major target of soluble TWEAK
Jose Antonio Carmona Arana et al.
FRONTIERS IN IMMUNOLOGY (2014)
Engineering death receptor ligands for cancer therapy
Harald Wajant et al.
CANCER LETTERS (2013)
Antibody-based fusion proteins to target death receptors in cancer
Marco de Bruyn et al.
CANCER LETTERS (2013)
Structure of the extracellular domains of human and Xenopus Fn14: implications in the evolution of TWEAK and Fn14 interactions
Maria Pellegrini et al.
FEBS JOURNAL (2013)
Fibroblast Growth Factor Inducible (Fn14)-specific Antibodies Concomitantly Display Signaling Pathway-specific Agonistic and Antagonistic Activity
Steffen Salzmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Activating Fc γ receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies
Yannick Bulliard et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
APG350 Induces Superior Clustering of TRAIL Receptors and Shows Therapeutic Antitumor Efficacy Independent of Cross-Linking via Fcγ Receptors
Christian Gieffers et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Dimerization of LTβR by LTα1β2 is necessary and sufficient for signal transduction
Jawahar Sudhamsu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Antitumor activities of agonistic anti-TNFR antibodies require differential FcγRIIB coengagement in vivo
Fubin Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
CD95 in cancer: tool or target?
Ana Martin-Villalba et al.
TRENDS IN MOLECULAR MEDICINE (2013)
S-SAD phasing study of death receptor 6 and its solution conformation revealed by SAXS
Heng Ru et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2012)
Properties of mouse and human IgG receptors and their contribution to disease models
Pierre Bruhns
BLOOD (2012)
Studies of Binding of Tumor Necrosis Factor (TNF)-like Weak Inducer of Apoptosis (TWEAK) to Fibroblast Growth Factor Inducible 14 (Fn14)
Andrea Fick et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Signaling Active CD95 Receptor Molecules Trigger Co-translocation of Inactive CD95 Molecules into Lipid Rafts
Isabell Lang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Crystal Structure of Human RANKL Complexed with Its Decoy Receptor Osteoprotegerin
Xudong Luan et al.
JOURNAL OF IMMUNOLOGY (2012)
A Death Effector Domain Chain DISC Model Reveals a Crucial Role for Caspase-8 Chain Assembly in Mediating Apoptotic Cell Death
Laura S. Dickens et al.
MOLECULAR CELL (2012)
Stoichiometry of the CD95 Death-Inducing Signaling Complex: Experimental and Modeling Evidence for a Death Effector Domain Chain Model
Kolja Schleich et al.
MOLECULAR CELL (2012)
Apoptotic and antitumor activity of death receptor antibodies require inhibitory Fcγ receptor engagement
Fubin Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Cellular Inhibitors of Apoptosis Are Global Regulators of NF-κB and MAPK Activation by Members of the TNF Family of Receptors
Eugene Varfolomeev et al.
SCIENCE SIGNALING (2012)
RANKL Employs Distinct Binding Modes to Engage RANK and the Osteoprotegerin Decoy Receptor
Christopher A. Nelson et al.
STRUCTURE (2012)
Soluble multi-trimeric TNF superfamily ligand adjuvants enhance immune responses to a HIV-1 Gag DNA vaccine
Saravana K. Kanagavelu et al.
VACCINE (2012)
An Fcγ Receptor-Dependent Mechanism Drives Antibody-Mediated Target-Receptor Signaling in Cancer Cells
Nicholas S. Wilson et al.
CANCER CELL (2011)
Structural basis for improved efficacy of therapeutic antibodies on defucosylation of their Fc glycans
Tsunehiro Mizushima et al.
GENES TO CELLS (2011)
Crystallographic and Mutational Analysis of the CD40-CD154 Complex and Its Implications for Receptor Activation
Hyun-Jung An et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Smac Mimetics Activate the E3 Ligase Activity of cIAP1 Protein by Promoting RING Domain Dimerization
Rebecca Feltham et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Structural Basis for FcγRIIa Recognition of Human IgG and Formation of Inflammatory Signaling Complexes
Paul A. Ramsland et al.
JOURNAL OF IMMUNOLOGY (2011)
Interaction with FcγRIIB Is Critical for the Agonistic Activity of Anti-CD40 Monoclonal Antibody
Ann L. White et al.
JOURNAL OF IMMUNOLOGY (2011)
The Crystal Structure of Death Receptor 6 (DR6): A Potential Receptor of the Amyloid Precursor Protein (APP)
Miriam Kuester et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
Development of an Fn14 agonistic antibody as an anti-tumor agent
Jennifer S. Michaelson et al.
MABS (2011)
Expression and Purification of a Natural N-Terminal Pre-ligand Assembly Domain of Tumor Necrosis Factor Receptor 1 (TNFR1 PLAD) and Preliminary Activity Determination
Jin Cao et al.
PROTEIN JOURNAL (2011)
Antagonists Induce a Conformational Change in cIAP1 That Promotes Autoubiquitination
Erin C. Dueber et al.
SCIENCE (2011)
Inhibitory Fcγ Receptor Engagement Drives Adjuvant and Anti-Tumor Activities of Agonistic CD40 Antibodies
Fubin Li et al.
SCIENCE (2011)
Decoy Strategies: The Structure of TL1A:DcR3 Complex
Chenyang Zhan et al.
STRUCTURE (2011)
The Structure of the Trimer of Human 4-1BB Ligand Is Unique among Members of the Tumor Necrosis Factor Superfamily
Eun-Young Won et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Membrane Tumor Necrosis Factor (TNF) Induces p100 Processing via TNF Receptor-2 (TNFR2)
Hilka Rauert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Soluble and Transmembrane TNF-Like Weak Inducer of Apoptosis Differentially Activate the Classical and Noncanonical NF-κB Pathway
Claudia Roos et al.
JOURNAL OF IMMUNOLOGY (2010)
Structural and Functional Insights of RANKL-RANK Interaction and Signaling
Changzhen Liu et al.
JOURNAL OF IMMUNOLOGY (2010)
Asymmetric Recruitment of cIAPs by TRAF2
Peter D. Mace et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Molecular and Structural Insight into proNGF Engagement of p75NTR and Sortilin
Dan Feng et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Crystal Structures of the TRAF2: cIAP2 and the TRAF1: TRAF2: cIAP2 Complexes: Affinity, Specificity, and Regulation
Chao Zheng et al.
MOLECULAR CELL (2010)
Structural and functional insights into 5′-ppp RNA pattern recognition by the innate immune receptor RIG-I
Yanli Wang et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Structure-based development of a receptor activator of nuclear factor-κB ligand (RANKL) inhibitor peptide and molecular basis for osteopetrosis
Hai Minh Ta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Solution of the Structure of the TNF-TNFR2 Complex
Yohei Mukai et al.
SCIENCE SIGNALING (2010)
Solution NMR Investigation of the CD95/FADD Homotypic Death Domain Complex Suggests Lack of Engagement of the CD95 C Terminus
Diego Esposito et al.
STRUCTURE (2010)
1.8 Å structure of murine GITR ligand dimer expressed in Drosophila melanogaster S2 cells
Kausik Chattopadhyay et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2009)
Biochemical and Structural Characterization of the Human TL1A Ectodomain
Chenyang Zhan et al.
BIOCHEMISTRY (2009)
Specificity and affinity of human Fcγ receptors and their polymorphic variants for human IgG subclasses
Pierre Bruhns et al.
BLOOD (2009)
TNF-like weak inducer of apoptosis inhibits proinflammatory TNF receptor-1 signaling
A. Wicovsky et al.
CELL DEATH AND DIFFERENTIATION (2009)
Oligomerized tumor necrosis factor-related apoptosis inducing ligand strongly induces cell death in myeloma cells, but also activates proinflammatory signaling pathways
Daniela Berg et al.
FEBS JOURNAL (2009)
Biological Activity of Ectodysplasin A Is Conditioned by Its Collagen and Heparan Sulfate Proteoglycan-binding Domains
Lee Kim Swee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Trimer Stabilization, Oligomerization, and Antibody-Mediated Cell Surface Immobilization Improve the Activity of Soluble Trimers of CD27L, CD40L, 41BBL, and Glucocorticoid-Induced TNF Receptor Ligand
Agnes Wyzgol et al.
JOURNAL OF IMMUNOLOGY (2009)
Dimers and multimers of monoclonal IgGI exhibit higher in vitro binding affinities to Fcγ receptors
Yin Luo et al.
MABS (2009)
The Fas-FADD death domain complex structure unravels signalling by receptor clustering
Fiona L. Scott et al.
NATURE (2009)
Membrane-bound Fas ligand only is essential for Fas-induced apoptosis
Lorraine A. O' Reilly et al.
NATURE (2009)
Solution structure of the cysteine-rich domain in Fn14, a member of the tumor necrosis factor receptor superfamily
Fahu He et al.
PROTEIN SCIENCE (2009)
A novel humanized anti-human death receptor 5 antibody CS-1008 induces apoptosis in tumor cells without toxicity in hepatocytes
A. Yada et al.
ANNALS OF ONCOLOGY (2008)
LBY135, a novel anti-DR5 agonistic antibody induces tumor cell-specific cytotoxic activity in human colon tumor cell lines and xenografts
Jing Li et al.
DRUG DEVELOPMENT RESEARCH (2008)
Activity of soluble OX40 ligand is enhanced by oligomerization and cell surface immobilization
Nicole Mueller et al.
FEBS JOURNAL (2008)
TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFα
James E. Vince et al.
JOURNAL OF CELL BIOLOGY (2008)
Death receptor 5 mediated-apoptosis contributes to cholestatic liver disease
Kazuyoshi Takeda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Structural basis for ligand-mediated mouse GITR activation
Zhaocai Zhou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Evolution of GITRL immune function: Murine GITRL exhibits unique structural and biochemical properties within the TNF superfamily
Kausik Chattopadhyay et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts
Claudia Bossen et al.
BLOOD (2008)
X-ray crystal structure of TNF ligand family member TL1A at 2.1 Å
Tengchuan Jin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Assembly and structural properties of glucocorticoid-induced TNF receptor ligand: Implications for function
Kausik Chattopadhyay et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Enforced covalent trimerization increases the activity of the TNF ligand family members TRAIL and CD95L
D. Berg et al.
CELL DEATH AND DIFFERENTIATION (2007)
TRAIL signals to apoptosis in chronic lymphocytic leukaemia cells primarily through TRAIL-R1 whereas cross-linked agonistic TRAIL-R2 antibodies facilitate signalling via TRAIL-R2
Alessandro Natoni et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Lexatumumab (TRAIL-receptor 2 mAb) induces expression of DR5 and promotes apoptosis in primary and metastatic renal cell carcinoma in a mouse orthotopic model
Liang Zhang et al.
CANCER LETTERS (2007)
Dominant-negative effect of the heterozygous C104R TACI mutation in common variable immunodeficiency (CVID)
Lilit Garibyan et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Development and characterization of recombinant human Fc:OX40L fusion protein linked via a coiled-coil trimerization domain
Nicholas P. Morris et al.
MOLECULAR IMMUNOLOGY (2007)
The source of APRIL up-regulation in human solid tumor lesions
P. Mhawech-Fauceglia et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
The crystal structure of the costimulatory OX40-OX40L complex
Deanne M. Compaan et al.
STRUCTURE (2006)
Multimeric soluble CD40 ligand and GITR ligand as adjuvants for human immunodeficiency virus DNA vaccines
GW Stone et al.
JOURNAL OF VIROLOGY (2006)
Restoration of membrane TNF-like activity by cell surface targeting and matrix metalloproteinase-mediated processing of a TNF prodrug
J Gerspach et al.
CELL DEATH AND DIFFERENTIATION (2006)
FcγRIV:: A novel FcR with distinct IgG subclass specificity
F Nimmerjahn et al.
IMMUNITY (2005)
Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation
J Hendriks et al.
CELL DEATH AND DIFFERENTIATION (2005)
Identification of proteoglycans as the APRIL-specific binding partners
K Ingold et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
HGS-ETR1, a fully human TRAIL-receptor 1 monoclonal antibody, induces cell death in multiple tumour types in vitro and in vivo
L Pukac et al.
BRITISH JOURNAL OF CANCER (2005)
The extracellular domains of FasL and Fas are sufficient for the formation of supramolecular FasL-Fas clusters of high stability
F Henkler et al.
JOURNAL OF CELL BIOLOGY (2005)
Structures of APRIL-receptor complexes - Like BCMA, TACI employs only a single cysteine-rich domain for high affinity ligand binding
SG Hymowitz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA
ES Day et al.
BIOCHEMISTRY (2005)
Receptor-selective mutants of apoptosis-inducing ligand 2/tumor necrosis factor-related apoptosis-inducing ligand reveal a greater contribution
RF Kelley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Induction of tumor-specific T cell immunity by anti-DR5 antibody therapy
K Takeda et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
The crystal structure of a proliferation-inducing ligand, APRIL
HJA Wallweber et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Structure of nerve growth factor complexed with the shared neurotrophin receptor p75
XL He et al.
SCIENCE (2004)
The crystal structures of EDA-A1 and EDA-A2: Splice variants with distinct receptor specificity
SG Hymowitz et al.
STRUCTURE (2003)
TWEAK induces NF-κB2 p100 processing and long lasting NF-κB activation
T Saitoh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
FcγRs modulate cytotoxicity of anti-fas antibodies:: Implications for agonistic antibody-based therapeutics
YY Xu et al.
JOURNAL OF IMMUNOLOGY (2003)
BAFF/BLyS receptor 3 comprises a minimal TNF receptor-like module that encodes a highly focused ligand-binding site
NC Gordon et al.
BIOCHEMISTRY (2003)
Ligand-receptor binding revealed by the TNF family member TALL-1
YF Liu et al.
NATURE (2003)
Crystal structure of the BAFF-BAFF-R complex and its implications for receptor activation
HM Kim et al.
NATURE STRUCTURAL BIOLOGY (2003)
Anti-CD95-induced lethality requires radioresistant FcγRII+ cells -: A novel mechanism for fulminant hepatic failure
S Jodo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex
N Holler et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Novel signaling mechanism for soluble CD95 ligand synergy with anti-CD95 monoclonal antibodies for apoptosis and NF-κB nuclear translocation
S Xiao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Structural basis of BLyS receptor recognition
DA Oren et al.
NATURE STRUCTURAL BIOLOGY (2002)
Crystal structure of the extracellular domain of mouse RANK ligand at 2.2-Å resolution
S Ito et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Crystal structure of sTALL-1 reveals a virus-like assembly of TNF family ligands
YF Liu et al.
CELL (2002)
Crystal structure of extracellular human BAFF, a TNF family member that stimulates B lymphocytes
M Karpusas et al.
JOURNAL OF MOLECULAR BIOLOGY (2002)
Actin cytoskeleton is required for early apoptosis signaling induced by anti-Fas antibody but not Fas ligand in murine B lymphoma A20 cells
M Bando et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
The molecular architecture of the TNF superfamily
JL Bodmer et al.
TRENDS IN BIOCHEMICAL SCIENCES (2002)
Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity
K Ichikawa et al.
NATURE MEDICINE (2001)
The structure of a human type III Fcγ receptor in complex with Fc
S Radaev et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The TNF and TNF receptor superfamilies: Integrating mammalian biology
RM Locksley et al.
CELL (2001)
Crystal structure of TRAIL-DR5 complex identifies a critical role of the unique frame insertion in conferring recognition specificity
SS Cha et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
The 3.2-Å crystal structure of the human IgG1 Fc fragment-FcγRIII complex
P Sondermann et al.
NATURE (2000)
A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling
FKM Chan et al.
SCIENCE (2000)
Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations
RM Siegel et al.
SCIENCE (2000)
Development of improved soluble inhibitors of FasL and CD40L based on oligomerized receptors
N Holler et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2000)
A unique zinc-binding site revealed by a high-resolution X-ray structure of homotrimeric Apo2L/TRAIL
SG Hymowitz et al.
BIOCHEMISTRY (2000)
Share Paper
